 Adjuvant radiation therapy patients detectable prostate specific antigen radical prostatectomy Adjuvant radiation therapy radical prostatectomy adenocarcinoma prostate patients patients lymph node metastasis seminal vesicle invasion positive lymph nodes positive surgical margins capsule penetration evidence residual disease detectable serum prostate specific antigen PSA Yang assay total patients subsequent decrease PSA ng./ml additional decrease PSA patients detectable PSA median followup months months radiation therapy patients detectable PSA radical prostatectomy durable response radiation therapy contrast patients delayed increase PSA durable response ability adjuvant radiation therapy serum PSA patients delayed increase PSA radical prostatectomy followup use nonradiated control subjects ability adjuvant radiation therapy local disease prolong patient survival